Compare · AHCO vs HIMS
AHCO vs HIMS
Side-by-side comparison of AdaptHealth Corp. (AHCO) and Hims & Hers Health Inc. (HIMS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AHCO and HIMS operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- HIMS is the larger of the two at $6.85B, about 7.9x AHCO ($871.2M).
- HIMS has been more active in the news (10 items in the past 4 weeks vs 2 for AHCO).
- HIMS has more recent analyst coverage (25 ratings vs 12 for AHCO).
- Company
- AdaptHealth Corp.
- Hims & Hers Health Inc.
- Price
- $6.03-5.85%
- $28.05-4.54%
- Market cap
- $871.2M
- $6.85B
- 1M return
- +4.42%
- -
- 1Y return
- -34.03%
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2018
- 2019
- News (4w)
- 2
- 10
- Recent ratings
- 12
- 25
AdaptHealth Corp.
AdaptHealth Corp., together with its subsidiaries, provides home healthcare equipment, medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; home medical equipment (HME) to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial payors. The company is headquartered in Plymouth Meeting, Pennsylvania.
Hims & Hers Health Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
Latest AHCO
- Amendment: SEC Form SCHEDULE 13G/A filed by AdaptHealth Corp.
- Amendment: SEC Form SCHEDULE 13G/A filed by AdaptHealth Corp.
- CHIEF FINANCIAL OFFICER Currie Harriss T was granted 141,372 shares (SEC Form 4)
- New insider Currie Harriss T claimed no ownership of stock in the company (SEC Form 3)
- AdaptHealth To Participate in Upcoming Investor Conferences
- AdaptHealth Corp. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- AdaptHealth Appoints Harriss Currie as Chief Financial Officer
- ReDream Brands Launches as the Leading Direct-to-Consumer Platform for Sleep Apnea and Sleep Health
- Director Samet Kenneth A bought $149,930 worth of shares (23,500 units at $6.38), increasing direct ownership by 94% to 48,569 units (SEC Form 4)
- Director Wolf Dale B bought $244,600 worth of shares (40,000 units at $6.12), increasing direct ownership by 16% to 143,234 units (SEC Form 4)
Latest HIMS
- SEC Form 4 filed by Hims & Hers Health Inc.
- SEC Form 3 filed by Hims & Hers Health Inc.
- Hims & Hers to Announce Third Quarter 2026 Financial Results on November 9, 2026
- Hers Launches in Australia, Built to Care for the Whole Woman
- SEC Form 8-K filed by Hims & Hers Health Inc.
- Hims & Hers Names Jon Franklin as Chief Accounting Officer
- Chief Financial Officer Okupe Oluyemi sold $59,400 worth of shares (2,000 units at $29.70) as part of a pre-agreed trading plan, decreasing direct ownership by 0.85% to 234,527 units (SEC Form 4)
- Chief Legal Officer Boughton Soleil sold $100,957 worth of shares (3,461 units at $29.17) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 300,809 units (SEC Form 4)
- Hims & Hers Names Chief Medical Officers in the UK and Australia, Deepening its Investment in Local Clinical Leadership
- Chief Financial Officer Okupe Oluyemi sold $876,846 worth of shares (29,277 units at $29.95) as part of a pre-agreed trading plan and exercised 14,000 shares at a strike of $5.01, decreasing direct ownership by 6% to 236,527 units (SEC Form 4)